Croce CMMicroRNA Dysregulation in Acute Myeloid Leukemia.J Clin Oncol 31(17) 2065-6 6/10/2013
Garofalo M, Croce CMMicroRNAs as therapeutic targets in chemoresistance.Drug Resist Updat in press 6/8/2013
Mussnich P, D'Angelo D, Leone V, Croce CM, Fusco AThe High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.Mol Oncol 7(3) 531-42 6/1/2013
Galli R, Paone A, Fabbri M, Zanesi N, Calore F, Cascione L, Acunzo M, Stoppacciaro A, Tubaro A, Lovat F, Gasparini P, Fadda P, Alder H, Volinia S, Filippini A, Ziparo E, Riccioli A, Croce CMToll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression.Proc Natl Acad Sci U S A in press 5/28/2013
Zanesi N, Balatti V, Riordan J, Burch A, Rizzotto L, Palamarchuk A, Cascione L, Lagana A, Dupuy AJ, Croce CM, Pekarsky YA Sleeping Beauty screen reveals NF-kB activation in CLL mouse model.Blood 121(21) 4355-8 5/23/2013
Vecchione A, Belletti B, Lovat F, Volinia S, Chiappetta G, Giglio S, Sonego M, Cirombella R, Onesti EC, Pellegrini P, Califano D, Pignata S, Losito S, Canzonieri V, Sorio R, Alder H, Wernicke D, Stoppacciaro A, Baldassarre G, Croce CMA microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.Proc Natl Acad Sci U S A in press 5/22/2013
Acunzo M, Romano G, Palmieri D, Laganá A, Garofalo M, Balatti V, Drusco A, Chiariello M, Nana-Sinkam P, Croce CMCross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2.Proc Natl Acad Sci U S A 110(21) 8573-8 5/21/2013
Mace TA, Collins AL, Wojcik SE, Croce CM, Lesinski GB, Bloomston MHypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells.J Surg Res in press 5/18/2013
Fassan M, Volinia S, Palatini J, Pizzi M, Fernandez-Cymering C, Balistreri M, Realdon S, Battaglia G, Souza R, Odze RD, Zaninotto G, Croce CM, Rugge Md Facg MMicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia.Clin Transl Gastroenterol 4 e34 5/16/2013
Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso FDiscovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation.ACS Chem Biol in press 5/13/2013
Chen Y, Jacamo R, Konopleva M, Garzon R, Croce C, Andreeff MCXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.J Clin Invest in press 5/8/2013
Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola V, Hofmeister CC, Marcucci G, Byrd JC, Volinia S, Shapiro CL, Freitas MA, Croce CMIn vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.J Exp Med 210(5) 951-68 5/6/2013
Tili E, Michaille JJ, Croce CMMicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer.Immunol Rev 253(1) 167-84 5/1/2013
Volinia S, Croce CMPrognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer.Proc Natl Acad Sci U S A 110(18) 7413-7 4/30/2013
Trotta R, Chen L, Costinean S, Josyula S, Mundy-Bosse BL, Ciarlariello D, Mao C, Briercheck EL, McConnell KK, Mishra A, Yu L, Croce CM, Caligiuri MAOverexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells.Blood 121(16) 3126-34 4/18/2013
Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Ramasamy S, Marcucci G, Perrotti D, Powell KA, Bratasz A, Garofalo M, Nephew KP, Croce CMCorrection: Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status.PLoS Genet 9(4) 4/1/2013
Balatti V, Lerner S, Rizzotto L, Rassenti LZ, Bottoni A, Palamarchuk A, Cascione L, Alder H, Keating MJ, Kipps TJ, Pekarsky Y, Croce CMTrisomy 12 CLLs progress through NOTCH1 mutations.Leukemia 27(3) 740-3 3/1/2013
Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T, Volinia S, Croce CMLoss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.Oncogene in press 2/18/2013
Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S, Liu CG, Schetter AJ, Roosbroeck K, Stephens RM, Calin GA, Croce CM, Ambs STranscription signatures encoded by ultraconserved genomic regions in human prostate cancer.Mol Cancer 12 13 2/14/2013
Di Leva G, Croce CMmiRNA profiling of cancer.Curr Opin Genet Dev 23(1) 3-11 2/1/2013
Fabbri M, Paone A, Calore F, Galli R, Croce CMA new role for microRNAs, as ligands of Toll-like receptors.RNA Biol 10(2) 169-74 2/1/2013
Gaudio E, Paduano F, Ngankeu A, Lovat F, Fabbri M, Sun HL, Gasparini P, Efanov A, Peng Y, Zanesi N, Shuaib MA, Rassenti LZ, Kipps TJ, Li C, Aqeilan RI, Lesinski GB, Trapasso F, Croce CMHeat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas.Blood 121(2) 351-9 1/10/2013
Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Ramasamy S, Marcucci G, Perrotti D, Powell KA, Bratasz A, Garofalo M, Nephew KP, Croce CMEstrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.PLoS Genet 9(3) e1003311 1/1/2013
Cascione L, Gasparini P, Lovat F, Carasi S, Pulvirenti A, Ferro A, Alder H, He G, Vecchione A, Croce CM, Shapiro CL, Huebner KIntegrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.PLoS One 8(2) e55910 1/1/2013
Nana-Sinkam SP, Croce CMClinical applications for microRNAs in cancer.Clin Pharmacol Ther 93(1) 98-104 1/1/2013
Hassan MQ, Maeda Y, Taipaleenmaki H, Zhang W, Jafferji M, Gordon JA, Li Z, Croce CM, Van Wijnen AJ, Stein JL, Stein GS, Lian JBmiR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells.J Biol Chem 287(50) 42084-92 12/7/2012
Sandhu SK, Volinia S, Costinean S, Galasso M, Neinast R, Santhanam R, Parthun MR, Perrotti D, Marcucci G, Garzon R, Croce CMmiR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model.Proc Natl Acad Sci U S A 109(49) 20047-52 12/4/2012
Laganà A, Paone A, Veneziano D, Cascione L, Gasparini P, Carasi S, Russo F, Nigita G, Macca V, Giugno R, Pulvirenti A, Shasha D, Ferro A, Croce CMmiR-EdiTar: a database of predicted A-to-I edited miRNA target sites.Bioinformatics 28(23) 3166-8 12/1/2012
Colamaio M, Calì G, Sarnataro D, Borbone E, Pallante P, Decaussin-Petrucci M, Nitsch L, Croce CM, Battista S, Fusco ALet-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene.J Clin Endocrinol Metab 97(11) E2168-78 11/1/2012
Paduano F, Ortuso F, Campiglia P, Raso C, Iaccino E, Gaspari M, Gaudio E, Mangone G, Carotenuto A, Bilotta A, Narciso D, Palmieri C, Agosti V, Artese A, Gomez-Monterrey I, Sala M, Cuda G, Iuliano R, Perrotti N, Scala G, Viglietto G, Alcaro S, Croce CM, Novellino E, Fusco A, Trapasso FIsolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity.ACS Chem Biol 7(10) 1666-76 10/19/2012
Taccioli C, Chen H, Jiang Y, Liu XP, Huang K, Smalley KJ, Farber JL, Croce CM, Fong LYDietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature.Oncogene 31(42) 4550-8 10/18/2012
Romano G, Acunzo M, Garofalo M, Di Leva G, Cascione L, Zanca C, Bolon B, Condorelli G, Croce CMMiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation.Proc Natl Acad Sci U S A 109(41) 16570-5 10/9/2012
Tili E, Michaille JJ, Luo Z, Volinia S, Rassenti LZ, Kipps TJ, Croce CMThe down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.Blood 120(13) 2631-8 9/27/2012
Hudson RS, Yi M, Esposito D, Glynn SA, Starks AM, Yang Y, Schetter AJ, Watkins SK, Hurwitz AA, Dorsey TH, Stephens RM, Croce CM, Ambs SMicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer.Oncogene in press 9/17/2012
Quintavalle C, Donnarumma E, Iaboni M, Roscigno G, Garofalo M, Romano G, Fiore D, De Marinis P, Croce CM, Condorelli GEffect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells.Oncogene in press 9/10/2012
Callegari E, Elamin BK, Giannone F, Milazzo M, Altavilla G, Fornari F, Giacomelli L, D'Abundo L, Ferracin M, Bassi C, Zagatti B, Corrà F, Miotto E, Lupini L, Bolondi L, Gramantieri L, Croce CM, Sabbioni S, Negrini MLiver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.Hepatology 56(3) 1025-33 9/1/2012
Alder H, Taccioli C, Chen H, Jiang Y, Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM, Fong LYDysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer.Carcinogenesis 33(9) 1736-44 9/1/2012
Ranganathan P, Yu X, Na C, Santhanam R, Shacham S, Kauffman M, Walker A, Klisovic R, Blum W, Caligiuri M, Croce CM, Marcucci G, Garzon RPreclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia.Blood 120(9) 1765-73 8/30/2012
Smith KM, Guerau-de-Arellano M, Costinean S, Williams JL, Bottoni A, Mavrikis Cox G, Satoskar AR, Croce CM, Racke MK, Lovett-Racke AE, Whitacre CCmiR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis.J Immunol 189(4) 1567-76 8/15/2012
Kriss CL, Pinilla-Ibarz JA, Mailloux AW, Powers JJ, Tang CH, Kang CW, Zanesi N, Epling-Burnette PK, Sotomayor EM, Croce CM, Del Valle JR, Hu CCOverexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice.Blood 120(5) 1027-38 8/2/2012
Mathé E, Nguyen GH, Funamizu N, He P, Moake M, Croce CM, Hussain SPInflammation regulates microRNA expression in cooperation with p53 and nitric oxide.Int J Cancer 131(3) 760-5 8/1/2012
Piovan C, Palmieri D, Di Leva G, Braccioli L, Casalini P, Nuovo G, Tortoreto M, Sasso M, Plantamura I, Triulzi T, Taccioli C, Tagliabue E, Iorio MV, Croce CMOncosuppressive role of p53-induced miR-205 in triple negative breast cancer.Mol Oncol 6(4) 458-72 8/1/2012
Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, Zanesi N, Crawford M, Ozer GH, Wernicke D, Alder H, Caligiuri MA, Nana-Sinkam P, Perrotti D, Croce CMMicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response.Proc Natl Acad Sci U S A 109(31) E2110-6 7/31/2012
Wang H, Chiu M, Xie Z, Chiu M, Liu Z, Chen P, Liu S, Byrd JC, Muthusamy N, Garzon R, Croce CM, Marcucci G, Chan KKSynthetic microRNA cassette dosing: pharmacokinetics, tissue distribution and bioactivity.Mol Pharm 9(6) 1638-44 6/4/2012
Iorio MV, Croce CMmicroRNA involvement in human cancer.Carcinogenesis 33(6) 1126-33 6/1/2012
Pero R, Palmieri D, Angrisano T, Valentino T, Federico A, Franco R, Lembo F, Klein-Szanto AJ, Del Vecchio L, Montanaro D, Keller S, Arra C, Papadopoulou V, Wagner SD, Croce CM, Fusco A, Chiariotti L, Fedele MPOZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.J Biol Chem 287(22) 18308-17 5/25/2012
Ranganathan P, Heaphy CE, Costinean S, Stauffer N, Na C, Hamadani M, Santhanam R, Mao C, Taylor PA, Sandhu S, He G, Shana'ah A, Nuovo GJ, Lagana A, Cascione L, Obad S, Broom O, Kauppinen S, Byrd JC, Caligiuri MA, Perrotti D, Hadley GA, Marcucci G, Devine SM, Blazar BR, Croce CM, Garzon RRegulation of acute graft-versus-host disease by microRNA-155.Blood 119(20) 4786-97 5/17/2012
Iorio MV, Croce CMCauses and consequences of microRNA dysregulation.Cancer J 18(3) 215-22 5/1/2012
Di Leva G, Briskin D, Croce CMMicroRNA in cancer: new hopes for antineoplastic chemotherapy.Ups J Med Sci 117(2) 202-16 5/1/2012
Trotta R, Chen L, Ciarlariello D, Josyula S, Mao C, Costinean S, Yu L, Butchar JP, Tridandapani S, Croce CM, Caligiuri MAmiR-155 regulates IFN-γ production in natural killer cells.Blood 119(15) 3478-85 4/12/2012
Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S, Lee TJ, Kim T, Bakàcs A, Alder H, Kaur B, Aqeilan RI, Pichiorri F, Croce CMMicroRNAs/TP53 feedback circuitry in glioblastoma multiforme.Proc Natl Acad Sci U S A 109(14) 5316-21 4/3/2012
Hudson RS, Yi M, Esposito D, Watkins SK, Hurwitz AA, Yfantis HG, Lee DH, Borin JF, Naslund MJ, Alexander RB, Dorsey TH, Stephens RM, Croce CM, Ambs SMicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer.Nucleic Acids Res 40(8) 3689-703 4/1/2012
Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, Leblanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan RImiRNA signatures associate with pathogenesis and progression of osteosarcoma.Cancer Res 72(7) 1865-77 4/1/2012
Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, Huebner K, Croce CMBreast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA.Proc Natl Acad Sci U S A 109(8) 3024-9 2/21/2012
Quintavalle C, Garofalo M, Zanca C, Romano G, Iaboni M, Del Basso De Caro M, Martinez-Montero JC, Incoronato M, Nuovo G, Croce CM, Condorelli GmiR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ.Oncogene 31(7) 858-68 2/16/2012
Palamarchuk A, Yan PS, Zanesi N, Wang L, Rodrigues B, Murphy M, Balatti V, Bottoni A, Nazaryan N, Alder H, Rassenti L, Kipps TJ, Freitas M, Croce CM, Pekarsky YTcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL).Proc Natl Acad Sci U S A 109(7) 2555-60 2/14/2012
Acunzo M, Visone R, Romano G, Veronese A, Lovat F, Palmieri D, Bottoni A, Garofalo M, Gasparini P, Condorelli G, Chiariello M, Croce CMmiR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.Oncogene 31(5) 634-42 2/2/2012
Balatti V, Bottoni A, Palamarchuk A, Alder H, Rassenti LZ, Kipps TJ, Pekarsky Y, Croce CMNOTCH1 mutations in CLL associated with trisomy 12.Blood 119(2) 329-31 1/12/2012
Gaudio E, Spizzo R, Paduano F, Luo Z, Efanov A, Palamarchuk A, Leber AS, Kaou M, Zanesi N, Bottoni A, Costinean S, Rassenti LZ, Nakamura T, Kipps TJ, Aqeilan RI, Pekarsky Y, Trapasso F, Croce CMTcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.Blood 119(1) 180-7 1/5/2012
Pekarsky Y, Croce CM, Bottoni A, Zanesi N, Balatti VNovel insights in molecular mechanisms of CLL.Curr Pharm Des 18(23) 3363-72 1/1/2012
Garofalo M, Quintavalle C, Romano G, Croce CM, Condorell GmiR221/222 in cancer: their role in tumor progression and response to therapy.Curr Mol Med 12(1) 27-33 1/1/2012
Fassan M, Croce CM, Rugge MmiRNAs in precancerous lesions of the gastrointestinal tract.World J Gastroenterol 17(48) 5231-9 12/28/2011
Park JK, Kogure T, Nuovo GJ, Jiang J, He L, Kim JH, Phelps MA, Papenfuss TL, Croce CM, Patel T, Schmittgen TDmiR-221 silencing blocks hepatocellular carcinoma and promotes survival.Cancer Res 71(24) 7608-16 12/15/2011
Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, Nephew KP, Croce CMEGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers.Nat Med 18(1) 74-82 12/11/2011
Nana-Sinkam SP, Croce CMNon-coding RNAs in cancer initiation and progression and as novel biomarkers.Mol Oncol 5(6) 483-91 12/1/2011
Lovat F, Valeri N, Croce CMMicroRNAs in the pathogenesis of cancer.Semin Oncol 38(6) 724-33 12/1/2011
Garzon R, Croce CMMicroRNAs and cancer: introduction.Semin Oncol 38(6) 721-3 12/1/2011
Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T, De Falco G, Githanga J, Horn H, Nyagol J, Ott G, Palatini J, Pfreundschuh M, Rogena E, Rosenwald A, Siebert R, Croce CM, Stein HThe different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.Leukemia 25(12) 1869-76 12/1/2011
Motiwala T, Zanesi N, Datta J, Roy S, Kutay H, Checovich AM, Kaou M, Zhong Y, Johnson AJ, Lucas DM, Heerema NA, Hagan J, Mo X, Jarjoura D, Byrd JC, Croce CM, Jacob STAP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia.Blood 118(23) 6132-40 12/1/2011
Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM, Patel TmicroRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer.Oncogene 30(47) 4750-6 11/24/2011
Havelange V, Stauffer N, Heaphy CC, Volinia S, Andreeff M, Marcucci G, Croce CM, Garzon RFunctional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profiling.Cancer 117(20) 4696-706 10/15/2011
Fassan M, Volinia S, Palatini J, Pizzi M, Baffa R, De Bernard M, Battaglia G, Parente P, Croce CM, Zaninotto G, Ancona E, Rugge MMicroRNA expression profiling in human Barrett's carcinogenesis.Int J Cancer 129(7) 1661-70 10/1/2011
Quintavalle C, Garofalo M, Croce CM, Condorelli G"ApoptomiRs" in vascular cells: their role in physiological and pathological angiogenesis.Vascul Pharmacol 55(4) 87-91 10/1/2011
Grignol V, Fairchild ET, Zimmerer JM, Lesinski GB, Walker MJ, Magro CM, Kacher JE, Karpa VI, Clark J, Nuovo G, Lehman A, Volinia S, Agnese DM, Croce CM, Carson WE 3rdmiR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions.Br J Cancer 105(7) 1023-9 9/27/2011
Visone R, Veronese A, Rassenti LZ, Balatti V, Pearl DK, Acunzo M, Volinia S, Taccioli C, Kipps TJ, Croce CMmiR-181b is a biomarker of disease progression in chronic lymphocytic leukemia.Blood 118(11) 3072-9 9/15/2011
Havelange V, Pekarsky Y, Nakamura T, Palamarchuk A, Alder H, Rassenti L, Kipps T, Croce CMIRF4 mutations in chronic lymphocytic leukemia.Blood 118(10) 2827-9 9/8/2011
Abdeen SK, Salah Z, Maly B, Smith Y, Tufail R, Abu-Odeh M, Zanesi N, Croce CM, Nawaz Z, Aqeilan RIWwox inactivation enhances mammary tumorigenesis.Oncogene 30(36) 3900-6 9/8/2011
Ferracin M, Pedriali M, Veronese A, Zagatti B, Gafà R, Magri E, Lunardi M, Munerato G, Querzoli G, Maestri I, Ulazzi L, Nenci I, Croce CM, Lanza G, Querzoli P, Negrini MMicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.J Pathol 225(1) 43-53 9/1/2011
Croce CMmiRNAs in the spotlight: Understanding cancer gene dependency.Nat Med 17(8) 935-6 8/4/2011
Wan SG, Taccioli C, Jiang Y, Chen H, Smalley KJ, Huang K, Liu XP, Farber JL, Croce CM, Fong LYZinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression.Int J Cancer 129(2) 331-45 7/15/2011
Palmieri D, Valentino T, D'Angelo D, De Martino I, Postiglione I, Pacelli R, Croce CM, Fedele M, Fusco AHMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents.Oncogene 30(27) 3024-35 7/7/2011
Fabbri M, Croce CMRole of microRNAs in lymphoid biology and disease.Curr Opin Hematol 18(4) 266-72 7/1/2011
Sozzi G, Pastorino U, Croce CMMicroRNAs and lung cancer: from markers to targets.Cell Cycle 10(13) 2045-6 7/1/2011
Negrini M, Gramantieri L, Sabbioni S, Croce CMmicroRNA involvement in hepatocellular carcinoma.Anticancer Agents Med Chem 11(6) 500-21 7/1/2011